Vaccinations

Research into why protective antibodies fade after COVID-19 vaccines --NIH

Wed, 2024-10-30 13:46 — mike kraft

Why protective antibodies fade after COVID-19 vaccines New findings could help explain why the immune protection generated by COVID-19 vaccines tends to decline over time. National Institutes of Health (NIH)

Researchers found that current COVID-19 vaccines fail to generate mature and durable antibody-producing cells in the bone marrow.
The findings could help explain why protection tends to decline over time.
Better understanding of long-term immune responses could lead to improved vaccines that provide enduring protection.
...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about Research into why protective antibodies fade after COVID-19 vaccines --NIH
Log in or register to post comments

Distrust among various groups hindered COVID vaccination efforts --Brithis study

Mon, 2024-10-28 16:47 — mike kraft

'Perfect storm' of distrust deepened inequalities during COVID-19 pandemic

...

Research led by University of Manchester academics, examined the attitudes of people from minoritized ethnic groups, young adults and those with long-term physical and mental health conditions toward the COVID-19 vaccination program.

Researchers found that a "perfect storm" of marginalization and experience of structural inequalities led to distrust of the COVID-19 vaccination drive—and that marginalized communities felt "left behind" by policy and decision-makers prior to and during the pandemic.

...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Problem

Situation Report

Read more about Distrust among various groups hindered COVID vaccination efforts --Brithis study
Log in or register to post comments

U.S. limits on testing for bird flu in humans could pose difficulty for containing spread

Fri, 2024-10-25 15:01 — mike kraft

Limits on testing for bird flu in humans could pose difficulty for containing spread Tests will soon be available by prescription, but they are only recommended for people in close contact with animals The Guardian

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about U.S. limits on testing for bird flu in humans could pose difficulty for containing spread
Log in or register to post comments

U.S. CDC recommends expanding pneumococcal vaccines to adults aged 50-64

Thu, 2024-10-24 16:39 — mike kraft

U.S. CDC recommends expanding pneumococcal vaccines to adults aged 50-64

Oct 24 (Reuters) - The U.S. Centers for Disease Control and Prevention on Wednesday recommended expanding the use of vaccines to adults between 50-64 years to protect against pneumococcal disease.

The agency's earlier recommendation for vaccination was for adults 65 years or older and children younger than 5, as well as for children and adults with certain conditions.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Other

Read more about U.S. CDC recommends expanding pneumococcal vaccines to adults aged 50-64
Log in or register to post comments

COVID infections in pregnant women may affect newborn heart development --China study

Thu, 2024-10-24 15:06 — mike kraft

Maternal COVID infections may affect newborn heart development Ten percent of newborns in the COVID-19 group had abnormalities, compared with 4% in the control group. CIDRAP

Maternal COVID-19 infection during pregnancy may adversely affect the development of the newborn's heart, resulting in congenital heart defects (CHD), researchers suggested yesterday in Scientific Reports.

...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Read more about COVID infections in pregnant women may affect newborn heart development --China study
Log in or register to post comments

CDC Recommends Second Dose of 2024-2025 COVID-19 Vaccine for Older People And Those Who are Moderately or Severely Immunocompromised

Thu, 2024-10-24 14:57 — mike kraft

CDC Recommends Second Dose of 2024-2025 COVID-19 Vaccine for People 65 Years and Older and for People Who are Moderately or Severely Immunocompromised Today, CDC Director Mandy Cohen endorsed the CDC Advisory Committee on Immunization Practices’ (AC CDC CDC Newsroom

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Repeated COVID vaccinations found to enhance mucosal immunity in the nose against the virus

Thu, 2024-10-24 00:27 — mike kraft

Repeated COVID vaccinations found to enhance mucosal immunity against the virus During the COVID pandemic, many of us received multiple mRNA vaccines. New work by researchers at the VIB-UGent Center for Inflammation Research, Ghent University, and University Hospital Ghent, among ... VIB (the Flanders Institute for Biotechnology) Medical Xpress

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Read more about Repeated COVID vaccinations found to enhance mucosal immunity in the nose against the virus
Log in or register to post comments

RSV: US FDA approves Pfizer's RSV vaccine for older adults at increased risk

Wed, 2024-10-23 14:48 — mike kraft

US FDA approves Pfizer's RSV vaccine for adults at increased risk of the disease The U.S. Food and Drug Administration on Tuesday approved Pfizer's RSV vaccine for the prevention of lower respiratory tract disease caused by RSV in adults aged 18 to 59 at increased risk of the disease. Reuters Reuters

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about RSV: US FDA approves Pfizer's RSV vaccine for older adults at increased risk
Log in or register to post comments

Evaluating this year’s COVID booster as a good match for new variants

Mon, 2024-10-21 14:51 — mike kraft

Is this year’s COVID booster a good match for new variants? Depending on when you last got vaccinated, that COVID-19 shot may no longer be a good match for the variants expected to dominate this fall and winter. amartichoux The Hill

...

While they may not be a perfect match, the latest variants have enough in common with the KP.2 and JN.1 that the boosters should still offer effective cross-protection.

...

Country / Region Tags:

General Topic Tags: